DCF — SIOUXLAND SURGERY CENTER
Enterprise Value: $67.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$67.3M
Enterprise Value
$17.1M
PV of Cash Flows
$50.2M
PV of Terminal Value
$80.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $108.8M | $9.3M | 9.0% | $3.0M | $2.7M |
| Year 2 | $112.1M | $10.6M | 10.0% | $3.9M | $3.3M |
| Year 3 | $115.5M | $12.1M | 11.0% | $4.9M | $3.7M |
| Year 4 | $118.9M | $13.1M | 11.0% | $5.5M | $3.8M |
| Year 5 | $122.5M | $13.8M | 11.0% | $5.9M | $3.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $67.3M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$105.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.080000001892784
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5